Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis

Background: We the prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma (HCC) patients registered within the surveillance, epidemiology and end results (SEER) database.Methods: SEER database (2010-2013) has been queried through SEER*Stat program to determine the progno...

Full description

Saved in:
Bibliographic Details
Main Authors: Oweira, Hani (Author) , Mehrabi, Arianeb (Author)
Format: Article (Journal)
Language:English
Published: 23 Feb 2017
In: Expert review of gastroenterology & hepatology
Year: 2017, Volume: 11, Issue: 7, Pages: 695-701
ISSN:1747-4132
DOI:10.1080/17474124.2017.1294485
Online Access:Verlag, Volltext: http://dx.doi.org/10.1080/17474124.2017.1294485
Verlag, Volltext: https://doi.org/10.1080/17474124.2017.1294485
Get full text
Author Notes:Hani Oweira, Arianeb Mehrabi

MARC

LEADER 00000caa a2200000 c 4500
001 1572490896
003 DE-627
005 20230426124308.0
007 cr uuu---uuuuu
008 180430s2017 xx |||||o 00| ||eng c
024 7 |a 10.1080/17474124.2017.1294485  |2 doi 
035 |a (DE-627)1572490896 
035 |a (DE-576)502490896 
035 |a (DE-599)BSZ502490896 
035 |a (OCoLC)1341007785 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Oweira, Hani  |e VerfasserIn  |0 (DE-588)1155884973  |0 (DE-627)1018363904  |0 (DE-576)501927395  |4 aut 
245 1 0 |a Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma  |b a SEER database analysis  |c Hani Oweira, Arianeb Mehrabi 
264 1 |c 23 Feb 2017 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.04.2018 
520 |a Background: We the prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma (HCC) patients registered within the surveillance, epidemiology and end results (SEER) database.Methods: SEER database (2010-2013) has been queried through SEER*Stat program to determine the prognosis of advanced HCC patients according to the site of extra-hepatic disease. Survival analysis has been conducted through Kaplan Meier analysis.Results: A total of 4396 patients with stage IV HCC were identified in the period from 2010-2013 and they were included into this analysis. Patients with isolated regional lymph node involvement have better outcomes compared to patients with any other site of extra-hepatic disease (P < 0.0001 for both endpoints). Among patients with distant metastases, patients with bone metastases have better outcomes compared to patients with lung metastases (P < 0.0001 for both endpoints). Multivariate analysis revealed that younger age, normal alpha fetoprotein, single site of extra-hepatic disease, local treatment to the primary tumor and surgery to the metastatic disease were associated with better overall survival and liver cancer-specific survival.Conclusion: Within the limits of the current SEER analysis, HCC patients with isolated lung metastases seem to have worse outcomes compared to patients with isolated bone or regional nodal metastases.​ 
650 4 |a bone metastases 
650 4 |a hepatocellular carcinoma 
650 4 |a Liver cancer 
650 4 |a lung metastases 
650 4 |a nodal metastases 
700 1 |a Mehrabi, Arianeb  |d 1967-  |e VerfasserIn  |0 (DE-588)137664583  |0 (DE-627)594829763  |0 (DE-576)304831263  |4 aut 
773 0 8 |i Enthalten in  |t Expert review of gastroenterology & hepatology  |d Abingdon, Oxon : Taylor & Francis, 2007  |g 11(2017), 7, Seite 695-701  |h Online-Ressource  |w (DE-627)594425875  |w (DE-600)2484623-5  |w (DE-576)398101035  |x 1747-4132  |7 nnas  |a Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma a SEER database analysis 
773 1 8 |g volume:11  |g year:2017  |g number:7  |g pages:695-701  |g extent:7  |a Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma a SEER database analysis 
856 4 0 |u http://dx.doi.org/10.1080/17474124.2017.1294485  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1080/17474124.2017.1294485  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180430 
993 |a Article 
994 |a 2017 
998 |g 137664583  |a Mehrabi, Arianeb  |m 137664583:Mehrabi, Arianeb  |d 910000  |d 910200  |e 910000PM137664583  |e 910200PM137664583  |k 0/910000/  |k 1/910000/910200/  |p 2  |y j 
998 |g 1155884973  |a Oweira, Hani  |m 1155884973:Oweira, Hani  |p 1  |x j 
999 |a KXP-PPN1572490896  |e 3007626668 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma a SEER database analysisExpert review of gastroenterology & hepatology","recId":"594425875","part":{"volume":"11","pages":"695-701","text":"11(2017), 7, Seite 695-701","extent":"7","issue":"7","year":"2017"},"id":{"eki":["594425875"],"issn":["1747-4132"],"zdb":["2484623-5"]},"origin":[{"publisher":"Taylor & Francis ; Informa Healthcare","dateIssuedKey":"2007","dateIssuedDisp":"2007-","publisherPlace":"Abingdon, Oxon ; London"}],"pubHistory":["1.2007 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 01.09.15"],"title":[{"title":"Expert review of gastroenterology & hepatology","title_sort":"Expert review of gastroenterology & hepatology"}]}],"note":["Gesehen am 30.04.2018"],"name":{"displayForm":["Hani Oweira, Arianeb Mehrabi"]},"recId":"1572490896","id":{"eki":["1572490896"],"doi":["10.1080/17474124.2017.1294485"]},"origin":[{"dateIssuedDisp":"23 Feb 2017","dateIssuedKey":"2017"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"7 S."}],"person":[{"family":"Oweira","given":"Hani","role":"aut","display":"Oweira, Hani"},{"display":"Mehrabi, Arianeb","family":"Mehrabi","given":"Arianeb","role":"aut"}],"title":[{"title":"Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma","subtitle":"a SEER database analysis","title_sort":"Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma"}]} 
SRT |a OWEIRAHANIPROGNOSTIC2320